7860
S. Zhang, G. S. Gerhard / Bioorg. Med. Chem. 16 (2008) 7853–7861
4. Woodrow, C. J.; Haynes, R. K.; Krishna, S. Postgrad.
Med. J. 2005, 81, 71–78.
4.3. Interaction of artemisinin and inorganic iron
5. Afonso, A.; Hunt, P.; Cheesman, S.; Alves, A. C.; Cunha,
C. V.; do Rosario, V.; Cravo, P. Antimicrob. Agents
Chemother. 2006, 50, 480–489.
6. Alin, M. H.; Bjorkman, A. Am. J. Trop. Med. Hyg. 1994,
50, 771–776.
7. Bilia, A. R.; Lazari, D.; Messori, L.; Taglioli, V.;
Temperini, C.; Vincieri, F. F. Life Sci. 2002, 70, 769–778.
8. Messori, L.; Piccioli, F.; Eitler, B.; Bergonzi, M. C.; Bilia,
A. R.; Vincieri, F. F. Bioorg. Med. Chem. Lett. 2003, 13,
4055–4057.
The time course of the reaction (consisting of 2 mM fer-
rocyanide and 8 mM artemisinin or hydrogen peroxide
in ammonium acetate (pH 5.0) or phosphate (pH 7.0)
buffer, with 30% DMSO) was recorded at 419 nm in
1-ml containing cuvette. The heme-competition experi-
ments were conducted in ammonium acetate buffer pH
5.0 (22% DMSO in final) in microplates with a total vol-
ume of 260 ll containing 20 lM heme, 40 lM artemisi-
nin, and various concentrations of ferrocyanide or
ferrous chloride at a range of molar ratios of inorganic
iron to heme from 0 to 80.
9. Meshnick, S. R. Antimicrob. Agents Chemother. 2003, 47,
2712, author reply 2712-3.
10. Robert, A.; Coppel, Y.; Meunier, B. Alkylation of Heme
by the Antimalarial Drug Artemisinin. In Chemical Com-
munications; Cambridge: England, 2002; Vol. 5.
11. Eckstein-Ludwig, U.; Webb, R. J.; Van Goethem, I. D.;
East, J. M.; Lee, A. G.; Kimura, M.; O’Neill, P. M.; Bray,
P. G.; Ward, S. A.; Krishna, S. Nature 2003, 424, 957–961.
12. Meshnick, S. R.; Yang, Y. Z.; Lima, V.; Kuypers, F.;
Kamchonwongpaisan, S.; Yuthavong, Y. Antimicrob.
Agents Chemother. 1993, 37, 1108–1114.
4.4. Interaction of artesunate with different forms of
hemoglobin
MetHb stock solution (0.5 mM in PBS) was used as the
initial source of hemoglobin for all experiments. The fi-
nal concentrations of various forms of hemoglobin in all
assays was 5 lM (equivalent to 20 lM hemin or heme
iron). The molar ratio of artesunate to hemoglobin
was 2:1, similar to that used in previous studies.17,30
Both deoxygenated hemoglobin (deoxyHb) and oxygen-
ated hemoglobin (oxyHb) were made from metHb using
dithionite. For deoxyHb, 10 ll of metHb solution was
first added to 980-ll reaction buffer solution, then satu-
rated dithionite stock solution was added. By doing so,
deoxyHb was formed because the oxygen in the reaction
solution was rapidly consumed by the dithionite, which
was confirmed by its characteristic absorption spectrum.
In order to make oxyHb, 150-ll concentrated metHb
solution (0.5 mM) was added to 2-ll saturated stock
dithionite solution to make a concentrated deoxyHb
solution. When 10 ll of this solution was added to
980-ll phosphate buffer solution, the deoxyHb was oxy-
genated to form oxyHb, confirmed by its characteristic
absorption spectral pattern. During 24-h incubations,
all cuvettes were sealed to prevent exposure to air.
13. Reeder, B. J.; Wilson, M. T. Chem. Research Toxicol.
2005, 18, 1004–1011.
14. Szpilman, A. M.; Korshin, E. E.; Hoos, R.; Posner, G. H.;
Bachi, M. D. J. Org. Chem. 2001, 66, 6531–6540.
15. Haynes, R. K.; Monti, D.; Taramelli, D.; Basilico, N.;
Parapini, S.; Olliaro, P. Antimicrob. Agents Chemother.
2003, 47, 1175.
16. Kannan, R.; Kumar, K.; Sahal, D.; Kukreti, S.; Chauhan,
V. S. Biochem. J. 2005, 385, 409–418.
17. Messori, L.; Gabbiani, C.; Casini, A.; Siragusa, M.;
Vincieri, F. F.; Bilia, A. R. Bioorg. Med. Chem. 2006,
14, 2972–2977.
18. Mercer, A. E.; Maggs, J. L.; Sun, X. M.; Cohen, G. M.;
Chadwick, J.; O’Neill, P. M.; Park, B. K. J. Biol. Chem.
2007, 282, 9372–9382.
19. Nam, W.; Tak, J.; Ryu, J. K.; Jung, M.; Yook, J. I.; Kim,
H. J.; Cha, I. H. Head Neck 2007, 29, 335–340.
20. Meshnick, S. R.; Thomas, A.; Ranz, A.; Xu, C. M.; Pan,
H. Z. Mol. Biochem. Parasitol. 1991, 49, 181–189.
21. Egan, T. J.; Ncokazi, K. K. J. Inorg. Biochem. 2004, 98, 144–152.
22. Hayward, R.; Saliba, K. J.; Kirk, K. J. Cell Sci. 2006, 119,
1016–1025.
4.5. Spectrophotometry
23. Yayon, A.; Cabantchik, Z. I.; Ginsburg, H. EMBO J.
1984, 3, 2695–2700.
24. Sullivan, D. J., Jr.; Gluzman, I. Y.; Russell, D. G.;
Goldberg, D. E. Proc. Natl. Acad. Sci. U.S.A. 1996, 93,
11865–11870.
25. Di Iorio, E. E. Preparation of Derivatives of Ferrous and
Ferric Hemoglobin. In Methods in Enzymology; Antonini,
E., Rossi-Bernadi, L., Chiancone, E., Eds.; Academic
Press, Inc.: New York, 1981; pp 57–72.
Assays with cuvettes were recorded on a SpectronicÒ
GenesysTM 5 instrument (Spectronic Instruments, Inc.
Rochester, NY) at room temperature. Readings on
microplates were done using a Spectra MAX250 micro-
plate reader (Sunnyvale, CA, USA).
26. Kannan, R.; Sahal, D.; Chauhan, V. S. Chem. Biol. 2002,
9, 321–332.
Acknowledgment
27. Dixon, M. Biochim. Biophys. Acta 1971, 226, 241–258.
28. Ljones, T.; Burris, R. H. Anal. Biochem. 1972, 45, 448–452.
29. Konstantinov, A. A.; Vygodina, T.; Capitanio, N.; Papa,
S. Biochim. Biophys. Acta 1998, 1363, 11–23.
This work was supported by funds from the Geisinger
Clinic.
30. Selmeczi, K.; Robert, A.; Claparols, C.; Meunier, B. FEBS
Lett. 2004, 556, 245–248.
31. Pandey, A. V.; Tekwani, B. L.; Singh, R. L.; Chauhan, V.
S. J. Biol. Chem. 1999, 274, 19383–19388.
32. Antonini, E.; Brunori, M. Hemoglobin and Myoglobin in
their Reactions with Ligands. In Frontiers of Biology
Specific Aspects of the Reactions of Hemoglobin with
Ligands; Neuberger, A., Tatum, E. L., Eds.; North-
Holland Publishing Co.: Amsterdam, 1971; pp 235–285.
References and notes
1. Meshnick, S. R.; Taylor, T. E.; Kamchonwongpaisan, S.
Microbiol. Rev. 1996, 60, 301–315.
2. Kapetanaki, S.; Varotsis, C. FEBS Lett. 2000, 474, 238–241.
3. Posner, G. H.; Oh, C. H.; Wang, D.; Gerena, L.; Milhous,
W. K.; Meshnick, S. R.; Asawamahasadka, W. J. Med.
Chem. 1994, 37, 1256–1258.